| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |